MetaCap

Pyxis Oncology Statistics

NASDAQ: PYXSHealth CareBiotechnology: Pharmaceutical PreparationsUSD

1.81+0.13 (+7.74%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Pyxis Oncology by the numbers

Pyxis Oncology has a market capitalization of $216.5 million based on 119.61M shares outstanding. With trailing EPS of $-1.27, Pyxis Oncology is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 14.9% below its 50-day average and 16.1% below its 200-day average.

Average daily trading volume is 1.06M shares, or about $1.9 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

PYXS valuation vs. peer median

PYXS compared with the median of 8 peer companies
MetricPYXSPeer medianDifference
Market cap$216.49M$216.08M+0%
Avg. volume1.06M799.55K+33%

Peer median across 8 companies: KROS, RCKT, ARCT, IMRX, ENTA, CYPH, VNDA, FTH.

Valuation

Market cap
$216.49M
Price / sales (latest FY)
15.62
EPS (TTM)
$-1.27

Price and trading

Previous close
1.68
Open
1.70
Day range
1.70 – 1.99
52-week range
1.03 – 5.55
52-week change
-62.29%
Beta
—
Volume
3.05M

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
216.49M
Forward Pe
-2.22
Eps
-1.27
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
5.55
Week52 Low
1.03
Avg Volume
1.06M
Shares Outstanding
119.61M
Ma50
2.13
Ma200
2.16
Earnings Date
Nov 5, 2026
Pct From52w High
-67.39%
Pct From52w Low
75.73%

Related